Brief: Results From Novan’S Exploratory Studies Further Demonstrate Antimicrobial Effect Of Nitricil™ Platform Technology With Nvn4100 In Companion Animal Health
June 7 (Reuters) - Novan Inc NOVN.O :
* RESULTS FROM NOVAN’S EXPLORATORY STUDIES FURTHER
DEMONSTRATE
ANTIMICROBIAL EFFECT OF NITRICIL™ PLATFORM TECHNOLOGY WITH
NVN4100 IN COMPANION ANIMAL HEALTH
* NOVAN INC - POSITIVE IN VITRO RESULTS DEMONSTRATE
ANTIMICROBIAL
EFFECT OF NVN4100 AGAINST A WIDE VARIETY OF BACTERIA
* NOVAN INC - NOVEL IN VIVO CANINE PYODERMA MODEL
ESTABLISHED
WHICH SERVES AS A TOOL FOR CONTINUED ASSESSMENT AND OPTIMIZATION
OF NEXT STEPS
Source text for Eikon: ID:nGNX6GdxnF
Further company coverage: NOVN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NVN Liquidation
See all newsBrief: Nvn Liquidation Says On April 30, Debtors Filed Notice Of Effective Date With Bankruptcy Court
Brief: Novan Received Notice From Nasdaq Notifying Co's Securities Will Be Delisted From Nasdaq
Brief: Novan Received Notice Of Delisting Or Failure To Satisfy Continued Listing Rule From Nasdaq
U.S. STOCKS ON THE MOVE-Lands' End, Energy sector
U.S. STOCKS ON THE MOVE-Biogen, NetApp, LyondellBasell